Headache Study to Compare Aggrenox Full Dose and Reduced Dose


Phase 3 Results N/A

Summary of Purpose

Tolerability of a four weeks treatment with Aggrenox® modified release capsules b.i.d, compared to reduced dose during the first two weeks of treatment in a double-blind, randomized controlled parallel group comparison trial among Taiwanese patients with previous TIA's or ischemic stroke.To monitor frequency and intensity of headaches and other safety parameters among Taiwanese patients with previous TIA's or...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 October 2013.

1 Sep 2002 10 Jan 2006 1 Apr 2003 1 Apr 2003 1 Oct 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment


Not available